Pharming (PHAR) Tax Rate (2020 - 2026)
Pharming's (PHAR) quarterly Tax Rate came in at 7.12% in Q2 2026, up 14793691798.0% YoY from N/an in Q2 2025, and down 328.23% on a QoQ basis from 3.12% in Q1 2026.
Powered by 
Analysis
Pharming (PHAR) Tax Rate (2020 - 2026) Analysis & Trends
Pharming (PHAR) has 7 years of Tax Rate data on file, last reported at 7.12% in Q2 2026.
- Quarterly Tax Rate rose 14793691798.0% year-over-year to 7.12% in Q2 2026, while the trailing twelve-month figure through Jun 2026 was 6.18% (down 5845.0% YoY) and the FY2025 annual result came in at 80.25%, up 11969.0% from the prior year.
- Tax Rate retreated to 7.12% in Q2 2026, from 3.12% in the prior quarter.
- In the past five years, Tax Rate ranged from a high of 39.44% in Q4 2024 to a low of 147936925.1% in Q2 2025.
- A 5-year average of 9081514.64% and a median of 1.08% in 2024 frame the typical range for Tax Rate.
- Annual changes were most pronounced in 2025 — Tax Rate plunged 2000000000 bps — and 2026, when it soared 2000000000 bps.
- Tracing PHAR's Tax Rate over 5 years: stood at 14.5% in 2022, then surged by 100 bps to 0.0% in 2023, then jumped by 182199582 bps to 39.44% in 2024, then plunged by 74 bps to 10.42% in 2025, then plunged by 168 bps to 7.12% in 2026.
- The last three Tax Rate figures came in at 7.12% (Q2 2026), 3.12% (Q1 2026), and 10.42% (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.87 Bn | 131.01 Bn | 2.84 Bn | 20.98% |
| 2 | Regeneron Pharmaceuticals | 85.57 Bn | 77.57 Bn | 3.93 Bn | 15.11% |
| 3 | Argenx Se | 63.51 Bn | 58.32 Bn | 1.37 Bn | -10.89% |
| 4 | Moderna | 58.19 Bn | 53.05 Bn | 52.00 Mn | -1.96% |
| 5 | Revolution Medicines | 44.07 Bn | 44.07 Bn | - | - |
| 6 | BeOne Medicines | 39.99 Bn | 34.89 Bn | 1.53 Bn | 24.15% |
| 7 | Alnylam Pharmaceuticals | 35.38 Bn | 32.07 Bn | 992.69 Mn | 7.49% |
| 8 | Royalty Pharma | 28.42 Bn | 27.58 Bn | - | - |
| 9 | Insmed | 27.41 Bn | 26.25 Bn | 358.27 Mn | -16.71% |
| 10 | Pharming | 781.07 Mn | 621.57 Mn | 141.47 Mn | 108.58% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 108.58% |
| Mar 31, 2026 | 10.53% |
| Dec 31, 2025 | 10.42% |
| Sep 30, 2025 | -40.94% |
| Mar 31, 2025 | 26.97% |
| Dec 31, 2024 | -3.29% |
| Sep 30, 2024 | -165.13% |
| Jun 30, 2024 | -18.09% |
| Mar 31, 2024 | -26.12% |
| Dec 31, 2023 | -12.19% |
| Sep 30, 2023 | 4.75% |
| Jun 30, 2023 | -18.05% |
| Mar 31, 2023 | -27.34% |
| Dec 31, 2022 | -14.50% |
| Sep 30, 2022 | -2.15% |
| Jun 30, 2022 | -21.28% |
| Mar 31, 2022 | -17.39% |
| Dec 31, 2021 | 55.29% |
| Sep 30, 2021 | 8.95% |
| Jun 30, 2021 | -12.64% |